Clinical characteristics of metabolic dysfunction-associated steatotic liver disease and its association with significant liver fibrosis in hospitalized patients with chronic hepatitis B: a single-center retrospective cross-sectional study
Coexistence of chronic hepatitis B (CHB) and metabolic dysfunction-associated steatotic liver disease (MASLD) is becoming more common in clinical settings, but the relationship between MASLD and significant liver fibrosis in CHB remains uncertain. To delineate the clinical profile of hospitalized CHB patients with conc...